The medical simulation firm reported SEK 254.5M in revenue for Q2, driven by strong license sales and margin expansion.
Surgical Science Sweden reported Q2 revenue of SEK 254.5 million, a 21.7% year-over-year increase. GAAP earnings per share stood at SEK 0.41, while license revenue surged to SEK 84.8 million from SEK 58.9 million in the prior-year period.
The gross margin improved to 69% from 65% a year earlier, reflecting higher-margin license sales. Cash flow from operating activities totaled SEK 15.3 million, slightly below the SEK 16.2 million recorded in the same quarter last year.
As of June 30, 2026, the company held SEK 658.4 million in cash and cash equivalents, up from SEK 610.2 million at the end of the previous year.